April 17 (Bloomberg) -- The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the last close unless otherwise stated.
The TA-25 Index lost 0.3 percent to 1,326.19 in Tel Aviv.
B Communications Ltd. (BCOM IT): The telecommunications company expects to receive about 364 million shekels ($106 million) in dividends from Bezeq Israeli Telecommunication Corp. in May. B Communications slid 2.1 percent to 110 shekels.
Delek The Israeli Fuel Corp. (DLKIS IT): Moody’s Midroog rated the fuel distributor’s planned 400 million-shekel bond placement A2 with a stable outlook. The new bonds and previously rated securities were placed on “watch list. Delek was unchanged at 115 shekels.
Globe Exploration LP (GLEX IT): The oil and gas explorer said the drilling start date at Ofek 1 will be postponed to as late as Aug. 1 because the company needs to import a new drilling machine. Delek dropped 3.9 percent to 0.05 shekel.
Jerusalem Economy Ltd. (ECJM IT): The real-estate leasing company said it raised gross proceeds of 199.2 million shekels from a sale of bonds. Jerusalem Economy lost 0.5 percent to 42.62 shekels.
Partner Communications Co. (PTNR IT): The country’s second-largest mobile phone company said it’s considering a bond offering of as much as 1.2 billion shekels. Partner fell 0.4 percent to 63.98 shekels.
Teva Pharmaceutical Industries Ltd. (TEVA IT): The U.S. Food and Drug Administration said the world’s largest maker of generic drugs’ Lansoprazole may clog oral syringes and feeding tubes and urged doctors not to dispense the drug in a syringe or tube.
Separately, Biogen Idec Inc. has identified high-risk patients taking its multiple sclerosis drug Tysabri who have a 1 percent chance of developing a potentially deadly brain infection from the medicine. Teva, which makes the Copaxone multiple sclerosis drug, gained 1.1 percent to 170.40 shekels.
To contact the reporter on this story: Ronit Goodman in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org